仁度生物 (688193.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(仁度生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 43,963,532.3741,865,033.4444,815,148.3847,313,965.0637,068,338.3141,263,469.3938,766,500.34
 营业收入(元) 43,963,532.3741,865,033.4444,815,148.3847,313,965.0637,068,338.3141,263,469.3938,766,500.34
二、营业总成本(元) 47,415,450.6444,678,817.3943,739,944.9647,481,838.9837,569,753.6448,877,572.2548,358,348.04
 营业成本(元) 9,198,661.267,708,915.318,713,080.049,201,034.596,568,458.067,251,392.847,589,540.97
 研发费用(元) 9,314,746.8910,505,545.9010,176,017.0111,431,669.8711,103,681.1210,082,649.338,518,167.13
 营业税金及附加(元) 246,006.84249,020.44244,779.04263,909.72231,442.35251,930.12217,823.34
 销售费用(元) 22,003,439.8921,220,543.8620,257,085.3423,109,743.3116,280,757.0125,460,514.4926,094,372.37
 管理费用(元) 7,664,081.776,767,641.487,223,829.285,726,795.476,539,473.107,366,442.667,135,378.28
 财务费用(元) -1,011,486.01-1,772,849.60-2,874,845.75-2,251,313.97-3,154,058.02-1,535,357.18-1,196,934.05
  其中:利息费用(元) 26,729.4251,607.94110,231.7423,795.68107,712.50169,898.74129,789.78
  其中:利息收入(元) 1,113,061.212,283,587.822,555,151.4514,326,514.84-8,642,092.851,686,127.131,354,324.95
 资产减值损失(元) -791,930.17-775,936.72-357,326.04-421,719.81-188,971.06-127,739.10-537,193.95
 信用减值损失(元) 150,283.26156,985.04-425,494.71-396,755.13-13,097.4396,215.59-316,272.34
三、其他经营收益
 加:公允价值变动收益(元) 2,104,013.91937,166.65620,808.32996,997.24-987,128.601,343,243.52-691,476.79
 加:投资收益(元) 1,304,784.721,339,304.13974,191.98331,250.003,278,301.89467,400.422,846,960.17
 其他收益(元) 1,263,523.221,707,097.381,486,340.5716,384,514.36-1,192,500.00113,934.90
 营业利润平衡项目(元) ---0.01----
四、营业利润(元) 578,756.67550,832.543,373,723.5316,726,412.741,534,178.47-4,642,482.43-8,175,895.71
 加:营业外收入(元) 144,845.11-33,030.83135,380.790.34--
 减:营业外支出(元) 52,339.71107,150.6033,612.63319,686.01345,109.842,056.13148,212.18
五、利润总额(元) 671,262.07443,681.943,373,141.7316,542,107.521,189,068.97-4,644,537.45-8,324,107.89
 减:所得税费用(元) 330,876.31-183,221.41-330,766.09-60,417.59-660,335.77-844,239.84-1,931,772.23
六、净利润(元) 340,385.76626,903.353,703,907.8216,602,525.101,849,404.75-3,800,297.61-6,392,335.66
(一)按经营持续性分类
  持续经营净利润(元) 340,385.76626,903.353,703,907.8216,602,525.101,849,404.75-3,800,297.61-6,392,335.66
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 340,385.76626,903.353,703,907.8216,602,525.101,849,404.75-3,800,297.61-6,392,335.66
 扣除非经常性损益后的净利润(元) -3,026,637.66-1,228,629.321,085,262.614,126,534.73130,708.86-4,681,726.43-9,873,972.97
七、每股收益
 一、基本每股收益(元) -0.030.090.420.04-0.09-0.16
 二、稀释每股收益(元) -0.030.090.450.04-0.09-0.16
八、其他综合收益(元) -659,396.68176,045.7868,675.78-581,380.72-312,044.652,031,445.91-516,674.56
 归属于母公司股东的其他综合收益(元) -659,396.68176,045.7868,675.78-581,380.72-312,044.652,031,445.91-516,674.56
九、综合收益总额(元) -319,010.92802,949.133,772,583.6016,021,144.381,537,360.10-1,768,851.70-6,909,010.22
 归属于母公司所有者的综合收益总额(元) -319,010.92802,949.133,772,583.6016,021,144.381,537,360.10-1,768,851.70-6,909,010.22
公告日期 2024-10-302024-08-302024-04-302024-04-302023-10-312023-08-012023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院